Keith Ward
Key Patent Issued in the US
SCOHIA PHARMA and Kuria Therapeutics Announce Issuance of Key Patent Covering Novel Nrf2 Activator KANAGAWA, Japan & LITTLE ROCK,...
top of page
Search
Keith Ward
Kuria Granted Exclusive Worldwide Rights to Novel Nrf2 Activator
Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2...
bottom of page